In the news

September 8, 2022

Anvil used to train cancer researchers in big data analysis

Purdue’s powerful Anvil supercomputer is being used to train a group of cancer researchers – from graduate students to professors and practicing physicians – on big data management, analysis and visualization skills.

August 31, 2022

Mesecar named interim director of Purdue Center for Cancer Research

Andrew Mesecar, the Walther Professor in Cancer Structural Biology, will serve as the interim director of the Purdue Center for Cancer Research (PCCR) during the current national search for a permanent leader.

New patent-pending method mass-produces antitumor cells to treat blood diseases and cancer

A Purdue University chemical engineer has improved upon traditional methods to produce off-the-shelf human immune cells that show strong antitumor activity, according to a paper published in the peer-reviewed journal Cell Reports.

Surprise $8.5 million estate gift will fund more than 40 years of cancer research

Thanks to an unexpected bequest of $8.5 million from fellow faculty member John Capaldi, Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, has funding to support more than 40 years’ worth of cancer research.

Purdue University research instrumental in early development of FDA-approved advanced prostate cancer diagnostic and treatment

A new precision treatment that offers hope for patients with advanced prostate cancer has been granted approval by the U.S. Food and Drug Administration.

September 30, 2021

Scientists reverse pancreatic cancer progression in ‘time machine’ made of human cells

Bumsoo Han, professor of mechanical engineering, has built a realistic model of a pancreatic structure that acts as a “time machine” to understand cancer and reverse its spread.

September 9, 2021

Tyler Trent endowment leads to breakthrough discoveries in cancer research

“Tyler dreamed of raising a million dollars for cancer research and we have raised $2.7 million in his endowment here,” said Dr. Timothy Ratliff, Robert Wallace Miller Director of Purdue University Center for Cancer Research. The funds have led to breakthrough discoveries in chemotherapeutic studies focusing on highly resistant tumors like the very ones Tyler was battling.

December 1, 2020

Treating cancers starts small: More than 100 Purdue scientists study cancer on the cellular level

The Purdue University Center for Cancer Research connects more than 110 researchers from across the university to study cancer on the cellular level. The work in PCCR’s labs advances understandings of cancer prevention, detection, diagnosis and treatment. One of those faculty members is Deborah Knapp, the Dolores L. McCall Professor of Comparative Oncology, who is performing an ultrasound on a dog. PCCR is the nation’s only National Cancer Institute basic laboratory cancer center that includes a college of veterinary medicine.

October 29, 2020

Testing drugs within a tumor may combat pancreatic cancer drug resistance, ‘time machine’ suggests

Bumsoo Han, a professor of mechanical engineering, developed a tool that is helping scientists to more efficiently discover and test new drugs for pancreatic cancer.

October 22, 2020

Technology shines the light on ovarian cancer treatments

A Purdue University scientist is working to use simple LED light to help determine if certain chemotherapy options will work for specific patients.